They found that in test tube studies the molecule not only prevents the protein from forming clumps but can also reverse this process. Then, using fruit flies with Alzheimer's disease, they showed that the same molecule effectively "cures" the insects of the disease.
Alzheimer's disease is the most common neurodegenerative disorder linked to protein misfolding and aggregation, or clumping. Previous studies in animal models have shown that clumping of a protein known as the Alzheimer beta (A-beta) peptide causes memory impairment and cognitive deficits similar to those in patients with Alzheimer's disease. When these clumps of protein are deposited in the brain they damage neurones (brain cells), although the mechanism involved is still not understood.
The new molecule - designed by scientists in Sweden - is a small protein known as an Affibody (an engineered binding protein). In this new study, researchers at the University of Cambridge and the Swedish University of Agricultural Sciences found that in test-tube experiments this protein binds to the A-beta peptide, preventing it from forming clumps and breaking up any clumps already present.
In a second experiment, they studied the effect of this Affibody in a Drosophila (fruit fly) model of Alzheimer's disease previously developed at Cambridge. Working with fruit flies that develop the fly equivalent of Alzhiemer's because they have been genetically engineered to produce the Abeta protein, they crossed these flies with a second line of flies genetically engineered to produce the Affibody.
They found that offspring - despite producing the A-beta protein - did not develop Alzhiemer's.
"Flies are our first 'biological test bench'for this new type of medicine. We wanted to know if it was at all possible to prevent the effects of the A-beta protein in the brain of a living organism", says Professor Torleif Härd, SLU.
"But the results are positive and we think we now how this molecule can be further developed to function as a medicine, although it is not possible to say how long this will take, or if it is possible to treat patients who have already developed the disease. The next step will be performing tests on mice."
The research will continue in collaboration with KTH and the biotech enterprise Affibody AB, Stockholm. The study is published in PLoS Biology.
More information:Professor Torleif Härd, SLU; email@example.com, +46-18 471 40 55
Pressofficer Carin Wrange: +46-70 247 84 22; Carin.Wrange@adm.slu.se
Carin Wrange | idw
Climate Impact Research in Hannover: Small Plants against Large Waves
17.08.2018 | Leibniz Universität Hannover
First transcription atlas of all wheat genes expands prospects for research and cultivation
17.08.2018 | Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung
New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference
Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
17.08.2018 | Event News
08.08.2018 | Event News
27.07.2018 | Event News
17.08.2018 | Physics and Astronomy
17.08.2018 | Information Technology
17.08.2018 | Life Sciences